Nasal Drug Delivery Systems Market Size Share Trends Forecast Analysis 2026

1. NASAL DRUG DELIVERY SYSTEMS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Nasal Drug Delivery Systems Market - Overview Global Nasal Drug Delivery Systems Market, by Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), by Container Type (Non-pressurized Containers and Pressurized Containers), by System Type (Multi-dose, Bi-dose, and Unit Dose), by Therapeutics Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 48.1 billion in 2018, and is projected to exhibit a CAGR of 6.3% over the forecast period (2018 – 2026). Novel drug delivery systems are one of the fastest growing segment in the pharmaceutical industry. Nasal is a transmucosal drug delivery system, used to administer drug through nasal cavity. Numerous studies are conducted to study the systemic bioavailability of drug and on nasal administration of vaccine, peptide and hormonal therapy, and other drugs which are usually delivered by parenteral route. Growth in nasal drug delivery system market is attributed to high advantages of nasal administration and increasing innovative nasal drug delivery systems. For instance, number of pharmaceutical and biopharmaceutical companies are adopting nasal drug delivery system for the treatment of acute migraine, pain management, Alzheimer disease etc. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/nasal- drug-delivery-systems-market-1944 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION For instance, in 2016, Lannett Company, Inc. received Abbreviated New Drug Application (ANDA) approval from the U.S. FDA for its Sumatriptan Nasal Spray intended for the treatment of migraine. Moreover, in June 2018, Impax Specialty Pharma, Inc., a specialty pharmaceutical company, received US FDA approval for Zomig Nasal Spray to treat acute migraine in patients aged 12 years and above. Furthermore, in 2017, FDA approved OptiNose U.S. Inc.’s Xhance, which is a novel combination of drug and device to deliver fluticasone propionate to treat nasal polyps. Such product launches with diverse therapeutic application are augmenting the nasal drug delivery systems market growth. Browse Market Data 40 Tables and 38 Figures spread through 180 Pages and in-depth TOC on "Nasal Drug Delivery Systems Market, by Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), by Container Type (Non-pressurized Containers and Pressurized Containers), by System Type (Multi Dose, Bi Dose, and Unit Dose), by Therapeutics Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), by End User (Hospitals and Home Care Settings) and by Region - Global Forecast to 2026” Market players in nasal drug delivery systems are focusing on inorganic strategies, in turn consolidating the market. For instance, in 2014, Endo International plc, acquired Natesto, the first and only testosterone nasal gel till that date, from Trimel BioPharma SRL, used for the treatment of hypogonadism via replacement therapy. Request a Sample copy of this reports: https://www.coherentmarketinsights.com/insight/request-sample/1944 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Furthermore, in 2015, Eli Lilly and Company acquired Locemia's intranasal glucagon, which was in phase III clinical testing for the treatment of hypoglycemia. Such product acquisition is expected to strengthen the company’s product portfolio, in turn strengthening the market share of the acquirer. Key takeaways of the Nasal Drug Delivery Systems Market: The global nasal drug delivery systems market is expected to expand at a CAGR of 6.3% during the forecast period (2018 – 2026), owing to increasing approvals for nasal drug delivery systems Nasal spray segment is expected to be dominant, owing to large number of products offered in this segment and increasing research to launch new products in this segment Some of the major players involved in global nasal drug delivery systems market include Merck & Co., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1944 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved